Seminars in Nephrology
Volume 25, Issue 4 , Pages 191-193 , July 2005

Systemic Hypertension: An Overview of the Problem

  • Norman M. Kaplan

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Norman M. Kaplan, MD, Department of Internal Medicine, Division of Hypertension, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8899.

References 

  1. Fields LE , Burt VL , Cutler JA , et al.   The burden of adult hypertension in the United States, 1999–2000 (A rising tide) . Hypertension 2004 . 2004;44:398–404
  2. Vasan RS , Beiser A , Seshadri S , et al.   Residual lifetime risk for developing hypertension in middle-aged women and men (The Framingham Study) . JAMA . 2002;287:1003–1010
  3. Mitchell GF , Parise H , Benjamin EJ , et al.   Changes in arterial stiffness and wave reflection with advancing age in healthy men and women (The Framingham Heart Study) . Hypertension . 2004;43:1239–1245
  4. Weiss R , Dziura J , Burgert TS , et al.   Obesity and the metabolic syndrome in children and adolescents . N Engl J Med . 2004;350:2362–2374
  5. Muntner P , He J , Cutler JA , et al.   Trends in blood pressure among children and adolescents . JAMA . 2004;291:1207–2113
  6. Nolte E , McKee M . Measuring the health of nations (Analysis of mortality amenable to health care) . BMJ . 2003;327:1129–1132
  7. Unal B , Critchley JA , Capewell S . Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000 . Circulation . 2004;109:1101–1107
  8. Williamson DF , Vinicor F , Bowman BA  Centers For Disease Control and Prevention Primary Prevention Working Group . Primary prevention of type 2 diabetes mellitus by lifestyle intervention (Implications for health policy) . Ann Intern Med . 2004;140:951–957
  9. Julius S , Nesbitt S , Egan B , et al.   Trial of Preventing Hypertension (TROPHY) (Design and 2-year progress report) . Hypertension 2004 . 2004;44:146–151
  10. Lévy BI . Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system . Circulation . 2004;109:8–13
  11. Ebbeling CB , Pawlak DB , Ludwig DS . Childhood obesity (Public-health crisis, common sense cure) . Lancet . 2002;360:473–482
  12. Singhal A , Cole TJ , Fewtrell M , et al.   Is slower early growth beneficial for long-term cardiovascular health? . Circulation . 2004;109:1108–1113
  13. Schroeder K , Fahey T , Ebrahim S . How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials . Arch Intern Med . 2004;164:722–732
  14. Chobanian AV , Bakris GL , Black HR , et al.   The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC-7 report . JAMA . 2003;289:2560–2572
  15. Collins R , Armitage J , Parish S , et al.  Heart Protection Study Collaborative Group   Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions . Lancet . 2004;363:757–767

PII: S0270-9295(05)00027-6

doi: 10.1016/j.semnephrol.2005.02.002

Seminars in Nephrology
Volume 25, Issue 4 , Pages 191-193 , July 2005

Article Tools